Hypercholesterolaemia, characterised by elevated levels of low-density lipoprotein (LDL) cholesterol in the blood, is a major ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

Recent clinical trials with a unique, potent, and selective cholesterol absorption inhibitor (ezetimibe) used in combination with lower doses of various statins showed an additive reduction in ...

Lerodalcibep is a novel, adnectin-based, small protein-binding, third-generation PCSK9 inhibitor, with long-ambient stability ... including the 30 million people with inherited high cholesterol, who ...

Controlling cholesterol absorption is thus crucial for maintaining ... With further advancements, drugs designed to inhibit Aster proteins could work alongside existing therapies, providing ...

Approved for use in 2002, ezetimibe works by inhibiting the intestinal absorption ... PCSK9 inhibitors are generally recommended for patients with a family history of high cholesterol.” ...

Combination Therapy Using a Cholesterol Absorption Inhibitor With a Statin The strategy of using a cholesterol synthesis inhibitor to maximize the cholesterol-lowering action of a cholesterol ...